The Patents (Amendment) (EU Exit) Regulations 2019

Type Statutory-Instrument
Publication 2019-04-04
State In force
Department King's Printer of Acts of Parliament
Reform history JSON API PDF

Made: 4th April 2019

Coming into force in accordance with regulation 1

A draft of these Regulations has been approved by resolutions of both Houses of Parliament pursuant to paragraph 1(1) of Schedule 7 to the European Union (Withdrawal) Act 2018 .

The Secretary of State, in exercise of the powers conferred by section 8(1) of the European Union (Withdrawal) Act 2018, makes the following Regulations:

PART 1 — INTRODUCTORY

1

These Regulations may be cited as the Patents (Amendment) (EU Exit) Regulations 2019 and come into force on exit day.

PART 2 — AMENDMENTS TO THE PATENTS ACT 1977

2

The Patents Act 1977 is amended follows.

3

In section 128A (EU compulsory licences)—

4

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PART 3 — AMENDMENT TO THE COPYRIGHT, DESIGNS AND PATENTS ACT 1988

5

PART 4 — AMENDMENTS TO THE PATENTS AND PLANT VARIETY RIGHTS (COMPULSORY LICENSING) REGULATIONS 2002

6

The Patents and Plant Variety Rights (Compulsory Licensing) Regulations 2002 are amended as set out in this Part.

7
  • “plant breeders’ right” means— any right granted under, or having effect as if granted under, section 3 of the 1997 Act (including existing rights as defined by section 40(4) of that Act); andany right which by virtue of regulation 3 of the Plant Breeders’ Rights (Amendment etc.) (EU Exit) Regulations 2019 is treated as if it were a plant breeders’ right granted in accordance with the 1997 Act and as if the variety were registered in accordance with regulations under section 18(1)(c) of the 1997 Act;
8
9

In regulation 7 (conditions), omit paragraphs (4) and (5).

10

Omit regulation 15 (Community plant variety rights.).

11

In regulation 16 (variation and revocation), omit paragraphs (4) to (7).

12

In regulation 17, for paragraph (2), substitute—

(2) Where a decision of the controllers relates to a compulsory patent licence or cross licence ordered to be granted under regulation 7(2) or 7(3), an appeal may be made to the court.

13
14
15

In regulation 24, omit “or 15(1)”.

16

Transitional provision

17

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PART 5 — AMENDMENTS TO THE PATENTS RULES 2007

18

PART 6 — SUPPLEMENTARY PROTECTION CERTIFICATES FOR PLANT PROTECTION PRODUCTS – AMENDMENTS TO REGULATION (EC) No 1610/96

19

Regulation (EC) No 1610/96 of the European Parliament and of the Council of 23 July 1996 concerning the creation of a supplementary protection certificate for plant protection products is amended as set out in this Part.

20

(11) ‘comptroller’ means the Comptroller-General of Patents, Designs and Trade Marks; (12) ‘court’ means— (a) as respects England and Wales, the High Court; (b) as respects Scotland, the Court of Session; (c) as respects Northern Ireland, the High Court in Northern Ireland; (13) ‘EEA authorization’ means an authorization to place a plant protection product on the market which has effect in an EEA state in accordance with Regulation(EC) No 1107/2009; (14) ‘patent’ means a patent which has effect in the United Kingdom; (15) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

21

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

22

For Article 2, substitute—

A plant protection product may, under the terms and conditions provided for in this Regulation, be the subject of a certificate if it is— (a) protected by a patent; and (b) the subject of a GB or NI authorization prior to being placed on the market as a plant protection product.

23

For Article 3(1), substitute—

(1) Where an application is submitted under Article 7, a certificate shall be granted if at the date of submission of the application— (a) the product is protected by a basic patent in force; (b) there is a valid GB or NI authorization to place the product on the market; (c) the product has not already been the subject of a certificate; (d) the authorization referred to in (b) is the first ... authorization to place the product on the market as a plant protection product in the territory of England and Wales and Scotland or the territory of Northern Ireland as the case may be.

24

(iv) the number and date of the GB or NI authorisation or both GB and NI authorisations as referred to in Article 3(1)(b) and (d); and (v) the number and date of the earliest EEA authorization, the granting of which predates the granting of the GB or NI authorization as referred to in Article 3(1)(b) and (d);

(b) a copy of the GB or NI authorisation or both GB and NI authorisations to place the product on the market, as referred to in Article 3(1)(b) and (d), in which the product is identified, containing in particular the number and date of the authorization and the summary of the product characteristics listed in Commission Regulation 283/2013, Part A section 1, points 1.1 to 1.7 or Part B, Section 1 points 1.1 to 1.4.3; (c) where the product is the subject of one or more EEA authorizations granted prior to the GB or NI authorization referred to in Article 3(1)(b) and (d), the applicant must provide in relation to the earliest of any such EEA authorizations— (i) information regarding the identity of the product thus authorised; (ii) information regarding the legal provision under which the authorization procedure took place; and (iii) a copy of the notice publishing the authorization in the appropriate official publication or, failing such a notice, any other document proving that the authorization has been issued, the date on which it was issued and the identity of the product authorized.

25

(1) An application for a certificate shall be lodged with the comptroller.

(d) the number and date of the GB or NI authorisation or both a GB and a NI authorisation provided under Article 8(1)(b), the product identified in the authorisation and the territory in respect of which the authorisation has been granted or has effect as if granted; (e) where there are EEA authorizations granted before any GB or NI authorisation provided under Article 8(1)(b), the number and date of the earliest EEA authorization;

26

(6) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

27

(e) where there are EEA authorizations granted before any authorisation provided under Article 8(1)(b), the number and date of the earliest EEA authorization;

28

Omit Article 12 (annual fees).

29

In paragraph 1 of Article 13 (duration of the certificate), for “the Community”, substitute “ the area comprising the European Economic Area and the United Kingdom ”.

30

(c) if the prescribed annual fee is not paid in time; or (d) if and as long as the product covered by the certificate may no longer be placed on the market following the withdrawal of all authorizations to place on the market in accordance with Article 28 of Regulation 1107/2009. The comptroller may decide on the lapse of the certificate either of the comptroller's own motion or at the request of a third party.

31

In paragraph (2) of Article 15 (invalidity of certificate), for “the body responsible under national law for the revocation of the corresponding basic patent” substitute “ the comptroller or the court ”.

32

In Article 16 (notification of lapse or invalidity), for “the authority referred to in Article 9(1)”, substitute “ the comptroller ”.

33

In Article 17 (appeals), omit paragraph 1.

34

In Article 18 (procedure), for paragraph 1 substitute—

(1) In the absence of procedural provisions in this Regulation, the procedural provisions applicable to the corresponding basic patent (as modified by section 128B of, and Schedule 4A to, the Patents Act 1977) shall apply to the certificate.

35

Omit Articles 19 and 20 (transitional provisions).

36

After Article 21 (entry into force), omit “This Regulation shall be binding in its entirety and directly applicable in all Member States.”.

PART 7 — COMPULSORY LICENSING OF PHARMACEUTICAL PATENTS - AMENDMENTS TO REGULATION (EC) NO 816/2006

37

Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems is amended as set out in this Part.

38
39

competent authority” for the purposes of Articles 1 to 11, 16 and 17 means the Comptroller-General of Patents, Designs and Trade Marks;

(5) “patent” means “a patent under the Patents Act 1977; (6) “supplementary protection certificate” means a supplementary protection certificate issued under Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products

40

In Article 4 (eligible importing countries), for “Commission”, substitute “ United Kingdom ”.

41
42

(1) Any person may submit an application for a compulsory licence under this Regulation to the competent authority in a case where that person's intended activities of manufacture and sale for export are covered by a patent or a supplementary protection certificate.

43

In Article 8 (verification), for “Commission”, wherever it occurs, substitute “ United Kingdom ”.

44
45
46

In Article 13 (prohibition of importation), in paragraph 1, for “Community”, substitute “ United Kingdom ”.

47
48
49

Omit Articles 17 to 19. (appeals, safety and efficacy of medicinal products and review)

50

After Article 20 (entry into force), omit “This Regulation shall be binding in its entirety and directly applicable in all Member States”.

PART 8 — SUPPLEMENTARY PROTECTION CERTIFICATES FOR MEDICINAL PRODUCTS – AMENDMENTS TO REGULATION (EC) No 469/2009

51

Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.